Sendero Wealth Management LLC acquired a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 4,044 shares of the conglomerate’s stock, valued at approximately $799,000.
Several other institutional investors have also recently made changes to their positions in DHR. GHP Investment Advisors Inc. lifted its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC grew its position in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher in the 1st quarter worth about $31,000. Dunhill Financial LLC lifted its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the period. Finally, Costello Asset Management INC bought a new stake in Danaher during the first quarter worth about $41,000. Institutional investors own 79.05% of the company’s stock.
Insider Activity at Danaher
In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on Danaher
Danaher Price Performance
Shares of NYSE:DHR opened at $215.05 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm has a market cap of $153.98 billion, a price-to-earnings ratio of 45.75, a price-to-earnings-growth ratio of 3.06 and a beta of 0.77. The business has a 50-day simple moving average of $200.19 and a two-hundred day simple moving average of $197.24. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the business posted $1.72 earnings per share. The business’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Basic Materials Stocks Investing
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- How to invest in marijuana stocks in 7 stepsĀ
- Starbucks Stock Slumps; This Competitor Shows Strength
- Bank Stocks – Best Bank Stocks to Invest In
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.